Client News

Roquefort Investments plc: Update on Acquisition of Lyramid Limited
Home / Client News / Roquefort Investments plc: Update on Acquisition of Lyramid Limited

Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector, is pleased to announce that it has commenced marketing to potential investors to fund the acquisition and pre-clinical drug development programme of Lyramid Limited, details of which were announced on 29 September 2021.  A copy of the presentation is available on the Company’s website at

The Company looks forward to providing further updates in relation to the acquisition of Lyramid Limited as and when appropriate.

The Company’s shares remain suspended from trading on the Main Market of the London Stock Exchange pending the publication of a Prospectus setting out full details of the potential transaction.



If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This